Insights

AI Health Collaborations Artrya is an AI healthcare company focused on improving diagnosis of coronary heart disease and predicting acute events, presenting a compelling opportunity to position compatible AI integration, data sharing, and co-development with hospitals and diagnostic networks.

US Expansion Significant U.S. expansion activity including a five-year Cone Health partnership and early-stage US commercial rollout suggests timing for up-selling Salix software licenses, expanded deployments, and multi-hospital integrative pilots.

Financial Momentum Recent financing rounds totaling multiple millions and a $60K revenue milestone in June 2026 indicate growing investor and customer interest; sales plays can emphasize value realization, ROI case studies, and scalable deployment across networks.

Strategic Partnerships Existing partnerships with Sonic Healthcare and Cone Health highlight a track record of collaboration with large clinical entities, signaling opportunities to target similarly sized health systems, ambulatory networks, and integrated delivery networks.

Data and Compliance Readiness Use of cloud and collaboration tools (AWS, Kubernetes, Jira, Slack) combined with AI platforms suggests readiness for enterprise-scale deployment, security, and governance conversations to support large-scale adoption and data interoperability.

Similar companies to Artrya Ltd

Artrya Ltd Tech Stack

Artrya Ltd uses 8 technology products and services including Matomo, Amazon Web Services, GitHub, and more. Explore Artrya Ltd's tech stack below.

Media & News

Artrya Ltd's Email Address Formats

Artrya Ltd uses at least 2 email formats:
Artrya Ltd Email FormatsExamplePercentage
First.Last@artrya.comJohn.Doe@artrya.com
98%
First.Middle@artrya.comJohn.Michael@artrya.com
2%

Frequently Asked Questions

What is Artrya Ltd's official website and social media links?

Minus sign iconPlus sign icon
Artrya Ltd's official website is artrya.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Artrya Ltd generate?

Minus sign iconPlus sign icon
As of October 2026, Artrya Ltd's annual revenue is estimated to be <$1M.

What is Artrya Ltd's NAICS code?

Minus sign iconPlus sign icon
Artrya Ltd's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Artrya Ltd have currently?

Minus sign iconPlus sign icon
As of October 2026, Artrya Ltd has approximately 67 employees across 3 continents, including Oceania, North America and Asia. Key team members include Chief Operating Officer: P. B. G., Chief People Officer (interim): S. R. and Chief Financial Officer: C. H. Explore Artrya Ltd's employee directory with LeadIQ.

What industry does Artrya Ltd belong to?

Minus sign iconPlus sign icon
Artrya Ltd operates in the Medical Equipment Manufacturing industry.

What technology does Artrya Ltd use?

Minus sign iconPlus sign icon
Artrya Ltd's tech stack includes Matomo, Amazon Web Services, GitHub, Kubernetes, WordPress, Microsoft 365, Atlassian Jira and Slack.

What is Artrya Ltd's email format?

Minus sign iconPlus sign icon
Artrya Ltd's email format typically follows the pattern of First.Last@artrya.com. Find more Artrya Ltd email formats with LeadIQ.

How much funding has Artrya Ltd raised to date?

Minus sign iconPlus sign icon
As of October 2026, Artrya Ltd has raised $15M in funding. The last funding round occurred on Jun 25, 2021 for $15M.

When was Artrya Ltd founded?

Minus sign iconPlus sign icon
Artrya Ltd was founded in 2018.
Artrya Ltd logo

Artrya Ltd

Medical Equipment ManufacturingWestern Australia, Australia51-200 Employees

Artrya is a Perth-based company operating in the medical equipment manufacturing sector that applies artificial intelligence to support clinicians in diagnosing coronary heart disease. Its work aims to provide a holistic view of patients at risk and to predict and prevent acute coronary events through AI-enabled analysis. The company employs a mid-sized team and focuses on integrating AI into cardiovascular diagnostics to complement clinical decision-making.

In February 2025, Artrya entered a collaboration with Sonic Healthcare to deploy its Salix platform under a three-year arrangement, extending its reach in clinical practice. Through such partnerships, the company aims to broaden its footprint within healthcare networks and advance AI-driven coronary anatomy assessment in real-world settings. The company is headquartered in Perth, Western Australia, and positions itself within the cardiovascular diagnostics market by working closely with clinicians.

Section iconCompany Overview

Website
artrya.com
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $15M

    Artrya Ltd has raised a total of $15M of funding over 1 rounds. Their latest funding round was raised on Jun 25, 2021 in the amount of $15M as a Series A.

  • <$1M

    Artrya Ltd's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.